Triple combination cream
Sponsors
Pontificia Universidad Catolica de Chile, Dr.dr.Irma Bernadette, SpKK (K), Indonesia University, Pak Emirates Military Hospital
Conditions
LentigoMelasmaMelasma (Facial Melasma)
Phase 2
Phase 4
Unknown Phase
Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy
RecruitingNCT06516419
Start: 2024-02-13End: 2025-03-30Target: 90Updated: 2024-07-24
Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma
Not yet recruitingNCT06780644
Start: 2025-02-17End: 2025-09-01Target: 56Updated: 2025-01-17